sponsored
PatientsVille.com Logo

PatientsVille

Albumin Medical Research Studies

Up-to-date List of Albumin Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Albumin Medical Research Studies

Rank Status Study
1 Not yet recruiting Hypoalbuminemia in Burn Patients
Condition: Second or Third Degree Burns
Intervention: Drug: 5% human albumin solution (HAS)
Outcome Measures: Organ dysfunction as assessed by a change in the SOFA score from baseline to day 7 (or before if the patient is discharged from the ICU or died).;   ICU and hospital mortality;   ICU and hospital length of stay;   Free days of mechanical ventilation;   Caloric intake;   Fluid balance;   Incidence of infection;   Time to complete coverage defined as the time between admission and last surgery for grafting
2 Unknown  Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
Conditions: End Stage Renal Disease;   Hypoalbuminemia;   Malnutrition
Intervention: Dietary Supplement: Protein Food Bar Intelligent Indulgence
Outcome Measures: The mean change (from baseline to month 3) in serum albumin levels among study groups and the proportion of patients treated with the protein food bar reaching an increase of 0.3 g/dL over the three month study period.;   Incidence of potential adverse events including nausea, vomiting, diarrhea, acidosis, and uremic symptoms as evidenced by clinical symptoms and possible worsening of laboratory measures such as BUN, Kt/V, nPNA and bicarbonate.;   Proportion of patients who reached the goal albumin of >3.5 g/dL during the study period;   Overall acceptance and compliance of bar form medical food over a 3 month period will be assessed via the proportion of patients who ingested 75% or more of the recommended bars.;   Impact of protein intake on laboratory measures such as pre-albumin, CRP and ferritin will be monitored
3 Recruiting Optimal Dosage of Caspofungin in Critically Ill Patients
Conditions: Critically Ill;   Suspected Invasive Candidiasis
Intervention: Drug: Caspofungin
Outcome Measures: The optimal dosage of caspofungin in relation to adequate exposure (measured as AUC) in critically ill patients.;   Pharmacokinetic parameters of caspofungin in critically ill patients.;   Correlation of pharmacokinetic parameters and the plasma concentration of caspofungin with disease severity scores.;   Correlation of the plasma concentration of caspofungin with candida eradication.;   Correlation of the plasma concentration of caspofungin with inflammation parameters.;   AUC/MIC ratio and highest observed plasma concentration (Cmax)/MIC ratio.;   Constructing a pharmacokinetic model of caspofungin in critically ill patients.;   Drug-related adverse events of caspofungin.

These studies may lead to new treatments and are adding insight into Albumin etiology and treatment.

A major focus of Albumin research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Albumin